Company · CIK 1885680

# TFA Therapeutics, Inc.

| CIK | [1885680](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001885680) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2833 — Medicinal Chemicals & Botanical Products |
| Listed | RAJAF (OTC) |
| First annual or quarterly report | 2023-05-15 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-269315 | IPO Final prospectus | 2023-01-20 | 2023-03-30 | 5 |

## Filings

 6

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2023-03-30 | [424B4](https://www.sec.gov/Archives/edgar/data/1885680/000121390023024460/0001213900-23-024460-index.htm) Final prospectus | 333-269315 | 0001213900-23-024460 |
| 2023-03-29 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1885680/999999999523000709/9999999995-23-000709-index.htm) Declared effective | 333-269315 | 9999999995-23-000709 |
| 2023-03-20 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1885680/000121390023021425/0001213900-23-021425-index.htm) Amendment | 333-269315 | 0001213900-23-021425 |
| 2023-03-06 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1885680/000121390023017720/0001213900-23-017720-index.htm) Amendment | 333-269315 | 0001213900-23-017720 |
| 2023-01-20 | [F-1](https://www.sec.gov/Archives/edgar/data/1885680/000121390023004029/0001213900-23-004029-index.htm) Registration filed | 333-269315 | 0001213900-23-004029 |
| 2021-12-06 | [DRS](https://www.sec.gov/Archives/edgar/data/1885680/000121390021063530/0001213900-21-063530-index.htm) Draft made public | 377-05758 | 0001213900-21-063530 |

[All filings of this company](https://equitycapital.markets/filings?cik=1885680) · [CSV](https://equitycapital.markets/filings.csv?cik=1885680)

---
Source page: https://equitycapital.markets/company/1885680 · Data: U.S. SEC EDGAR · CC BY 4.0